ClearPoint Neuro, Inc. financial data

Symbol
CLPT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
120 S. Sierra Avenue, Suite 100, Solana Beach, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
MRI INTERVENTIONS, INC. (to 2/11/2020), SURGIVISION INC (to 10/22/2010), SURGI VISION INC (to 5/2/2007)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 352 % -50.6%
Quick Ratio 66.1 % -56.3%
Debt-to-equity 61.8 % -2.03%
Return On Equity -62.1 % +14.1%
Return On Assets -38.4 % +13.4%
Operating Margin -61.9 % +37.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.6M shares +12%
Common Stock, Shares, Outstanding 27.6M shares +12%
Entity Public Float 155M USD -43%
Common Stock, Value, Issued 276K USD +12.2%
Weighted Average Number of Shares Outstanding, Basic 27.6M shares +12%
Weighted Average Number of Shares Outstanding, Diluted 27.6M shares +12%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 30.4M USD +36.3%
Revenue from Contract with Customer, Excluding Assessed Tax 30.4M USD +36.3%
Cost of Revenue 12.1M USD +28.9%
Research and Development Expense 11.7M USD -2.28%
Selling and Marketing Expense 14M USD +19%
Operating Income (Loss) -18.8M USD +15.1%
Net Income (Loss) Attributable to Parent -18.1M USD +17%
Earnings Per Share, Basic -0.68 USD/shares +24.4%
Earnings Per Share, Diluted -0.68 USD/shares +24.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.6M USD -11.4%
Accounts Receivable, after Allowance for Credit Loss, Current 3.88M USD +59.9%
Inventory, Net 7.06M USD -21.5%
Assets, Current 34.3M USD -7.99%
Property, Plant and Equipment, Net 1.7M USD +25.1%
Operating Lease, Right-of-Use Asset 3.21M USD -13%
Other Assets, Noncurrent 148K USD +35.8%
Assets 40.2M USD -8.31%
Accounts Payable, Current 955K USD +21%
Employee-related Liabilities, Current 3.64M USD +58.9%
Liabilities, Current 7.55M USD +35.2%
Operating Lease, Liability, Noncurrent 3.16M USD -14.5%
Liabilities 11.2M USD -43.3%
Retained Earnings (Accumulated Deficit) -186M USD -10.8%
Stockholders' Equity Attributable to Parent 29M USD +20.4%
Liabilities and Equity 40.2M USD -8.31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.84M USD +32.4%
Net Cash Provided by (Used in) Financing Activities 16.1M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 27.6M shares +12%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.6M USD -11.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 185K USD +3.35%
Deferred Tax Assets, Valuation Allowance 35.8M USD +18.8%
Deferred Tax Assets, Gross 35.9M USD +18.7%
Operating Lease, Liability 3.99M USD +90.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 6.35M USD +194%
Property, Plant and Equipment, Gross 2.33M USD -9.36%
Operating Lease, Liability, Current 536K USD +39.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 954K USD +63.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 869K USD +46.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +34.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.36M USD +3316%
Lessee, Operating Lease, Liability, to be Paid, Year Three 985K USD +103%
Deferred Tax Assets, Operating Loss Carryforwards 30.1M USD +13.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 502K USD +0.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 243K USD +88.4%
Deferred Tax Assets, Net of Valuation Allowance 38K USD -2.56%
Share-based Payment Arrangement, Expense 6.75M USD +18.2%
Interest Expense 598K USD -38.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%